ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
Get the latest NAV of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.
₹42.14
1D
NAV as on 27 Jun 2025
22.92%/per year
Since Inception
▲▼
6614 people have invested ₹ 5.4Cr in ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth in the last three months
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Performance vs. Nifty 500
Fund returns vs Benchmark returns vs Category Average returns as on (27-Jun-25)
The fund has consistently outperformed the benchmark (Nifty 500) over the last 1Y, 3Y, 5Y time periods.
INDmoney Rank
Powered by IND quant engine
IND ranking is not available for this fund.
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Returns Calculator
Calculate SIP and lumpsum returns based on historical performance
Total Investment
0
Profit
Total Corpus
0
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Asset Allocation
See fund asset allocation details as on (14-Jun-25)
Fund Distribution
as on (14-Jun-25)
Equity 97%
Debt & Cash 2.9%
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Sector Allocation
See fund sector allocation details as on (14-Jun-25)
Sector Allocation
Equity 97%
Debt & Cash 2.9%
Top 3 Sectors in May were Health, Basic Materials & Financial Services
Health
95%
Basic Materials
4%
Financial Services
1%
Health
94%
Basic Materials
5%
Financial Services
2%
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Holdings Details
as on (31-May-25)
Equity
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth Overview
Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.
| Expense ratio | 1.06% |
Benchmark | BSE Healthcare TR INR |
| AUM | ₹5508 Cr |
| Inception Date | 12 July, 2018 |
| Min Lumpsum/SIP | ₹5000/₹100 |
Exit Load | 1.0% |
| Lock In | No Lock-in |
TurnOver | 49.46% |
| STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
| LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
| Risk |   Very High Risk |
About ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth is an equity fund. This fund was started on 12 July, 2018. The fund is managed by Dharmesh Kakkad. The fund could potentially beat inflation in the long-run.
Key Parameters
- ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth has ₹5508 Cr worth of assets under management (AUM) as on Jun 2025 and is more than category average.
- The fund has an expense ratio 1.1.
Returns
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth has given a CAGR return of 22.92% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 23.01%, 30.63% and 25.35% respectively.
Holdings
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials, Financial Services. Its top holdings are Sun Pharmaceuticals Industries Ltd, Dr Reddy's Laboratories Ltd, Divi's Laboratories Ltd, Cipla Ltd, Aurobindo Pharma Ltd
Taxation
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
Investment objective of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.
Minimum Investment and lockin period
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 100.00. ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth has no lock in period.
Fund Manager
Dharmesh Kakkad
Fund Manager of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth, since 2 May 2020
- AUM of the fund stands at 5.5K Cr as of May'25
- AUM increased by 212.2 Cr between May'25 and Apr'25
More funds from ICICI
5Y CAGR
▲ 38.14
5Y CAGR
▲ 33.30
5Y CAGR
▲ 31.33
5Y CAGR
▲ 33.47
Compare ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund
VS
Nippon India Pharma Fund Direct Growth
Frequently Asked Questions for ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
How do I invest in ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund?
- Download the INDmoney app.
- Search for ‘ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund’.
- Select whether you want to invest in SIP or lump sum.
- Enter the amount you wish to invest.
- Set up payments via bank mandate or UPI.